Sinotherapeutics Inc. (SHA:688247)
China flag China · Delayed Price · Currency is CNY
9.69
-0.05 (-0.51%)
Mar 9, 2026, 4:00 PM EDT

Sinotherapeutics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
-225.79641.79763.15511.66
Upgrade
Short-Term Investments
--107.2144.09-
Upgrade
Trading Asset Securities
-507.74---
Upgrade
Cash & Short-Term Investments
765.54733.53749807.23511.66
Upgrade
Cash Growth
4.36%-2.07%-7.21%57.77%17.85%
Upgrade
Accounts Receivable
-110.9778.4771.2744.09
Upgrade
Other Receivables
-0.30.57--
Upgrade
Receivables
-111.2779.0471.2744.09
Upgrade
Inventory
-102.4284.6129.3840.43
Upgrade
Other Current Assets
-29.139.3645.8322.66
Upgrade
Total Current Assets
-976.32952.01953.71618.83
Upgrade
Property, Plant & Equipment
-344.34271.41255.92115.09
Upgrade
Long-Term Investments
-64.4264.249.169.99
Upgrade
Goodwill
-18.3918.3918.39-
Upgrade
Other Intangible Assets
-21.6527.5932.4741.16
Upgrade
Long-Term Deferred Tax Assets
-19.3314.2916.4516.08
Upgrade
Long-Term Deferred Charges
-0.921.211.993.15
Upgrade
Other Long-Term Assets
-7.9412.544.31.5
Upgrade
Total Assets
-1,4531,3621,332865.81
Upgrade
Accounts Payable
-16.7513.348.428.01
Upgrade
Accrued Expenses
-26.4914.6911.5814.19
Upgrade
Current Portion of Leases
-0.010.060.320.78
Upgrade
Current Income Taxes Payable
-6.971.280.457.85
Upgrade
Current Unearned Revenue
-30.4448.0156.846.78
Upgrade
Other Current Liabilities
-22.5413.3312.4711.92
Upgrade
Total Current Liabilities
-103.1990.7290.0589.52
Upgrade
Long-Term Leases
--0.021.23.66
Upgrade
Long-Term Unearned Revenue
-74.7258.0961.1264.62
Upgrade
Long-Term Deferred Tax Liabilities
-2.392.532.682.82
Upgrade
Total Liabilities
-180.3151.36155.05160.62
Upgrade
Common Stock
-453.34453.34453.34408
Upgrade
Additional Paid-In Capital
-513.57512.89512.89179.23
Upgrade
Retained Earnings
-342.22244.16211.19118.26
Upgrade
Treasury Stock
--36.13---
Upgrade
Comprehensive Income & Other
---0.13-0.15-0.31
Upgrade
Shareholders' Equity
1,3081,2731,2101,177705.19
Upgrade
Total Liabilities & Equity
-1,4531,3621,332865.81
Upgrade
Total Debt
0.020.010.091.524.44
Upgrade
Net Cash (Debt)
765.52733.53748.92805.71507.22
Upgrade
Net Cash Growth
4.36%-2.05%-7.05%58.85%16.82%
Upgrade
Net Cash Per Share
1.721.611.591.911.24
Upgrade
Filing Date Shares Outstanding
419.96449449.15453.34408
Upgrade
Total Common Shares Outstanding
449449453.34453.34408
Upgrade
Working Capital
-873.13861.29863.66529.31
Upgrade
Book Value Per Share
2.912.842.672.601.73
Upgrade
Tangible Book Value
1,2731,2331,1641,126664.02
Upgrade
Tangible Book Value Per Share
2.842.752.572.481.63
Upgrade
Buildings
-216.23211.6854.2952.41
Upgrade
Machinery
-183.49160.89145.6135.93
Upgrade
Construction In Progress
-80.7515.35153.614.68
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.